CD34 and glioblastoma: Hemorrhage, which is present in many GBM cases, has been linked to increased expression of angiogenic markers (CD34 and CD105), of some angiogenic genes—(HIF-1α and MDK) which share similar mechanisms of induction [81], and decreased expression of the Coagulation factor III (F3), enhancing susceptibility to hemorrhage.